Zofran, a GlaxoSmith Kline drug developed to treat nausea in those receiving cancer treatments, has become one of the top 20 brand-name drugs in the U.S. It has undoubtedly helped millions of cancer patients endure the side effects of radiation and chemotherapy and surgical patients ward off post-operative nausea.

However, over the years it has begun to be used for off-label purposes, including treatment of morning sickness in pregnant women. It was never intended for this use — nor has the FDA approved it as such — but doctors have prescribed it in these circumstances and have exposed families to untold heartache when their babies are born with serious birth defects.
Some of the Zofran-related birth defects leave the child disfigured, facing surgeries and long-lasting difficulties in their life. Some portend future health risks. And some result in death.
There have been numerous studies linking the off-label use of Zofran (Ondansetron) to birth defects. The reported problems include the following:
• Musculoskeletal deformities
• Heart murmurs
• Erratic heart rhythm
• Holes in the heart
• Kidney problems
• Low birth weight
• Cleft palate.
As in other situations where a prescription drug has been prescribed for unapproved conditions and harm resulted, victims may be able to obtain financial compensation, particularly if the pharmaceutical company is found to have encouraged the off-label use. The experienced pharmaceutical lawyers of Pogust Millrood are currently investigating the claims of families who have been hurt by the prescription of Zofran for nausea during pregnancy.
If you or a loved one has taken Zofran and experienced the sorrow and expense of giving birth to a baby with birth defects, please contact Pogust Millrood for a free consultation at (610) 941-4204 or contact us on our website: